ERBB2 and breast carcinoma: For instance, resveratrol acted as a proteasome inhibitor in breast cancer cells, inducing the accumulation of the ∆16HER2 splice variant of HER-2 [85], but promoted proteasomal degradation of Nanog in glioma stem cells [86].